Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin : The H2O Metabolism Pilot Study
(2019) In The Journal of clinical endocrinology and metabolism 104(6). p.1917-1925- Abstract
OBJECTIVE: Because elevated copeptin, a marker of vasopressin, is linked to low water intake and high diabetes risk, we tested the effect of water supplementation on copeptin and fasting glucose.
DESIGN, SETTING, AND PARTICIPANTS: Thirty-one healthy adults with high copeptin (>10.7 pmol · L-1 in men and >6.1 pmol·L-1 in women) identified in a population-based survey from 2013 to 2015 and with a current 24-hour urine osmolality of >600 mOsm · kg-1 were included.
INTERVENTION: Addition of 1.5 L water daily on top of habitual fluid intake for 6 weeks.
MAIN OUTCOME MEASURE: Pre- and postintervention fasting plasma copeptin concentrations.
RESULTS: Reported mean water intake increased from 0.43 to 1.35 L ·... (More)
OBJECTIVE: Because elevated copeptin, a marker of vasopressin, is linked to low water intake and high diabetes risk, we tested the effect of water supplementation on copeptin and fasting glucose.
DESIGN, SETTING, AND PARTICIPANTS: Thirty-one healthy adults with high copeptin (>10.7 pmol · L-1 in men and >6.1 pmol·L-1 in women) identified in a population-based survey from 2013 to 2015 and with a current 24-hour urine osmolality of >600 mOsm · kg-1 were included.
INTERVENTION: Addition of 1.5 L water daily on top of habitual fluid intake for 6 weeks.
MAIN OUTCOME MEASURE: Pre- and postintervention fasting plasma copeptin concentrations.
RESULTS: Reported mean water intake increased from 0.43 to 1.35 L · d-1 (P < 0.001), with no other observed changes in diet. Median (interquartile range) urine osmolality was reduced from 879 (705, 996) to 384 (319, 502) mOsm · kg-1 (P < 0.001); urine volume increased from 1.06 (0.90, 1.20) to 2.27 (1.52, 2.67) L · d-1 (P < 0.001); and baseline copeptin decreased from 12.9 (7.4, 21.9) pmol · L-1 to 7.8 (4.6;11.3) pmol · L-1 (P < 0.001). Water supplementation reduced fasting plasma glucose from a mean (SD) of 5.94 (0.44) to 5.74 (0.51) (P = 0.04). The water-associated reduction of both fasting copeptin and glucose concentration in plasma was most pronounced in participants in the top tertile of baseline copeptin.
CONCLUSIONS: Water supplementation in persons with habitually low water consumption and high copeptin levels is effective in lowering copeptin. It appears a safe and promising intervention with the potential of lowering fasting plasma glucose and thus reducing diabetes risk. Further investigations are warranted to support these findings.
(Less)
- author
- organization
- publishing date
- 2019-06-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The Journal of clinical endocrinology and metabolism
- volume
- 104
- issue
- 6
- pages
- 9 pages
- publisher
- Oxford University Press
- external identifiers
-
- scopus:85063756741
- pmid:30566641
- ISSN
- 1945-7197
- DOI
- 10.1210/jc.2018-02195
- language
- English
- LU publication?
- yes
- additional info
- Copyright © 2019 Endocrine Society.
- id
- e00c4d89-ef12-4d42-9fc1-b94975575fa4
- date added to LUP
- 2019-06-24 09:36:08
- date last changed
- 2025-01-23 18:25:35
@article{e00c4d89-ef12-4d42-9fc1-b94975575fa4, abstract = {{<p>OBJECTIVE: Because elevated copeptin, a marker of vasopressin, is linked to low water intake and high diabetes risk, we tested the effect of water supplementation on copeptin and fasting glucose.</p><p>DESIGN, SETTING, AND PARTICIPANTS: Thirty-one healthy adults with high copeptin (>10.7 pmol · L-1 in men and >6.1 pmol·L-1 in women) identified in a population-based survey from 2013 to 2015 and with a current 24-hour urine osmolality of >600 mOsm · kg-1 were included.</p><p>INTERVENTION: Addition of 1.5 L water daily on top of habitual fluid intake for 6 weeks.</p><p>MAIN OUTCOME MEASURE: Pre- and postintervention fasting plasma copeptin concentrations.</p><p>RESULTS: Reported mean water intake increased from 0.43 to 1.35 L · d-1 (P < 0.001), with no other observed changes in diet. Median (interquartile range) urine osmolality was reduced from 879 (705, 996) to 384 (319, 502) mOsm · kg-1 (P < 0.001); urine volume increased from 1.06 (0.90, 1.20) to 2.27 (1.52, 2.67) L · d-1 (P < 0.001); and baseline copeptin decreased from 12.9 (7.4, 21.9) pmol · L-1 to 7.8 (4.6;11.3) pmol · L-1 (P < 0.001). Water supplementation reduced fasting plasma glucose from a mean (SD) of 5.94 (0.44) to 5.74 (0.51) (P = 0.04). The water-associated reduction of both fasting copeptin and glucose concentration in plasma was most pronounced in participants in the top tertile of baseline copeptin.</p><p>CONCLUSIONS: Water supplementation in persons with habitually low water consumption and high copeptin levels is effective in lowering copeptin. It appears a safe and promising intervention with the potential of lowering fasting plasma glucose and thus reducing diabetes risk. Further investigations are warranted to support these findings.</p>}}, author = {{Enhörning, Sofia and Brunkwall, Louise and Tasevska, Irina and Ericson, Ulrika and Persson Tholin, Jenny and Persson, Margaretha and Lemetais, Guillaume and Vanhaecke, Tiphaine and Dolci, Alberto and Perrier, Erica T and Melander, Olle}}, issn = {{1945-7197}}, language = {{eng}}, month = {{06}}, number = {{6}}, pages = {{1917--1925}}, publisher = {{Oxford University Press}}, series = {{The Journal of clinical endocrinology and metabolism}}, title = {{Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin : The H2O Metabolism Pilot Study}}, url = {{http://dx.doi.org/10.1210/jc.2018-02195}}, doi = {{10.1210/jc.2018-02195}}, volume = {{104}}, year = {{2019}}, }